Skip to main content
. 2024 Jun 20;109(11):3593–3601. doi: 10.3324/haematol.2024.285256

Figure 1.

Figure 1.

The decision tree. The leftmost line shows the targeted patients: subjects with primary myelofibrosis (PMF) with an HLA-matched donor. The square is a decision node. The second line shows the two strategies that were compared: “Immediate hematopoietic cell transplantation” (HCT) and “Ruxolitinib treatment” (RUXO). At the decision node, we could decide to proceed to either of these. A Markov node (circled M) leads to a chance node, which is followed by two to four possible states.